Zwitterionic Modification of PSMA Ligands Reduces Off-Target Binding and Tissue Retention

Read full text
Authors: Lennart F. V. Spickschen, Roland Thünauer, Aleksander J. Swierzewski, John M. Van Wazer, Amanda Fears, Matthew D. Silva, Daniel L.J. Thorek, E. Oetjen, Wolfgang Maison
Cited by: 2
References: 63

Abstract

High Resolution Image Download MS PowerPoint Slide Off-target tissue retention is a serious limitation for prostate-specific membrane antigen (PSMA)-targeted drugs. This study addresses key questions regarding the role of zwitterionic modifications in PSMA-ligand design for tissue distribution. A series of fluorescent PSMA-ligands was synthesized and evaluated with respect to PSMA-binding, tumor uptake, and biodistribution in cell experiments and in mice. The data revealed that the introduction of two zwitterionic groups into the linker domain of the PSMA-specific conjugates was particularly advantageous. The resulting compound 10 combined high and specific PSMA-binding affinity (IC 50 = 4.39 ± 1.69 nM) and good uptake in tumor cells and tumor xenografts with extremely low off-target tissue retention. A major practical advantage of this strategy is its simple synthetic realization using solid-phase peptide synthesis with commercial building blocks and their modification using click-chemistry. Zwitterionization is therefore easily transferable to other targeting vectors and alternative effector molecules, for example in radiopharmaceuticals.

Fields of Study & Subjects

Prostate Cancer Treatment and Research Protein Degradation and Inhibitors Cancer Lipids and Metabolism

Publication details

Journal / source
Journal of Medicinal Chemistry
Publisher
American Chemical Society (ACS)
Volume
69
Issue
6
Pages
7364–7376
Publication date
13 March 2026
Language
EN